Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 21514322)

1.

Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signaling.

Bremer E, Abdulahad WH, de Bruyn M, Samplonius DF, Kallenberg CG, Armbrust W, Brouwers E, Wajant H, Helfrich W.

Immunol Lett. 2011 Aug 30;138(2):161-8. doi: 10.1016/j.imlet.2011.04.004. Epub 2011 Apr 15.

PMID:
21514322
2.

TNF-α confers resistance to Fas-mediated apoptosis in rheumatoid arthritis through the induction of soluble Fas.

Hong S, Kim EJ, Lee EJ, San Koo B, Min Ahn S, Bae SH, Lim DH, Kim YG, Yoo B, Lee CK.

Life Sci. 2015 Feb 1;122:37-41. doi: 10.1016/j.lfs.2014.12.008. Epub 2014 Dec 19.

PMID:
25529148
3.

A circulating reservoir of pathogenic-like CD4+ T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment.

Spreafico R, Rossetti M, van Loosdregt J, Wallace CA, Massa M, Magni-Manzoni S, Gattorno M, Martini A, Lovell DJ, Albani S.

Ann Rheum Dis. 2014 Dec 12. pii: annrheumdis-2014-206226. doi: 10.1136/annrheumdis-2014-206226. [Epub ahead of print]

4.

[Presence of riziform bodies in a patient with juvenile idiopathic arthritis: case report and literature review.]

Campos LR, Sztajnbok FC, Galvão S, Lessa MD, Aymoré IL, Sztajnbok F.

Rev Bras Reumatol. 2014 Oct 23. pii: S0482-5004(14)00192-2. doi: 10.1016/j.rbr.2014.09.002. [Epub ahead of print] Portuguese.

5.

Activation-induced cell death in T lymphocytes from multiple sclerosis patients.

Moreno M, Negrotto L, Río J, Moubarak R, Martín I, Bustamante MF, Comella JX, Vidal-Jordana A, Pérez-Boza J, Montalban X, Comabella M.

J Neuroimmunol. 2014 Jul 15;272(1-2):51-5. doi: 10.1016/j.jneuroim.2014.04.007. Epub 2014 Apr 16.

PMID:
24793898
6.

Bifunctional antibody fragment-based fusion proteins for the targeted elimination of pathogenic T-cell subsets.

Helfrich W, Bremer E.

Methods Mol Biol. 2014;1134:79-93. doi: 10.1007/978-1-4939-0326-9_7.

PMID:
24497356
7.

HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration.

Schierbeck H, Pullerits R, Pruunsild C, Fischer M, Holzinger D, Laestadius Å, Sundberg E, Harris HE.

J Rheumatol. 2013 Sep;40(9):1604-13. doi: 10.3899/jrheum.120987. Epub 2013 Jul 15.

PMID:
23858044
8.

Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis.

Dvergsten JA, Mueller RG, Griffin P, Abedin S, Pishko A, Michel JJ, Rosenkranz ME, Reed AM, Kietz DA, Vallejo AN.

Arthritis Rheum. 2013 Aug;65(8):2201-10. doi: 10.1002/art.38015.

9.

Design, expression and characterization of a novel coexpression system of two antiarthritic molecules.

Zhang W, Wang F, Yan J, Zhang X, Wang Y, Jiang Y, Wang L, Xu Y, Yu J.

Appl Microbiol Biotechnol. 2013 Jul;97(14):6301-14. doi: 10.1007/s00253-013-4787-z. Epub 2013 Mar 6.

PMID:
23463251
10.

Distinct different sensitivity of Treg and Th17 cells to Fas-mediated apoptosis signaling in patients with acute coronary syndrome.

Li Q, Wang Y, Wang Y, Zhou Q, Chen K, Wang YM, Wei W, Wang Y.

Int J Clin Exp Pathol. 2013;6(2):297-307. Epub 2013 Jan 15.

11.

The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients.

Pericolini E, Alunno A, Gabrielli E, Bartoloni E, Cenci E, Chow SK, Bistoni G, Casadevall A, Gerli R, Vecchiarelli A.

PLoS One. 2013;8(1):e53336. doi: 10.1371/journal.pone.0053336. Epub 2013 Jan 8.

12.

Comparison of blood and synovial fluid th17 and novel peptidase inhibitor 16 Treg cell subsets in juvenile idiopathic arthritis.

Grose RH, Millard DJ, Mavrangelos C, Barry SC, Zola H, Nicholson IC, Cham WT, Boros CA, Krumbiegel D.

J Rheumatol. 2012 Oct;39(10):2021-31. doi: 10.3899/jrheum.111421. Epub 2012 Aug 15.

PMID:
22896021
13.
14.

Osteoblastogenesis from synovial fluid-derived cells is related to the type and severity of juvenile idiopathic arthritis.

Lazić E, Jelušić M, Grčević D, Marušić A, Kovačić N.

Arthritis Res Ther. 2012 Jun 12;14(3):R139. doi: 10.1186/ar3872.

15.

Circulating and synovial antibody profiling of juvenile arthritis patients by nucleic acid programmable protein arrays.

Gibson DS, Qiu J, Mendoza EA, Barker K, Rooney ME, LaBaer J.

Arthritis Res Ther. 2012 Apr 17;14(2):R77. doi: 10.1186/ar3800.

16.

Cellular interactions of synovial fluid γδ T cells in juvenile idiopathic arthritis.

Bendersky A, Marcu-Malina V, Berkun Y, Gerstein M, Nagar M, Goldstein I, Padeh S, Bank I.

J Immunol. 2012 May 1;188(9):4349-59. doi: 10.4049/jimmunol.1102403. Epub 2012 Mar 26.

17.

Intraarticular gene delivery of CTLA4-FasL suppresses experimental arthritis.

Zhang W, Wang F, Wang B, Zhang J, Yu JY.

Int Immunol. 2012 Jun;24(6):379-88. doi: 10.1093/intimm/dxs041. Epub 2012 Feb 21.

18.

CTLA4-FasL fusion product suppresses proliferation of fibroblast-like synoviocytes and progression of adjuvant-induced arthritis in rats.

Zhang W, Wang B, Wang F, Zhang J, Yu J.

Mol Immunol. 2012 Mar;50(3):150-9. doi: 10.1016/j.molimm.2012.01.007. Epub 2012 Feb 10.

PMID:
22325471
19.
20.

Alginate encapsulated cells secreting Fas-ligand reduce lymphoma carcinogenicity.

Goren A, Gilert A, Meyron-Holtz E, Melamed D, Machluf M.

Cancer Sci. 2012 Jan;103(1):116-24. doi: 10.1111/j.1349-7006.2011.02124.x. Epub 2011 Nov 27.

PMID:
22017300
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk